STONERIDGE INVESTMENT PARTNERS LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1108831 RADNOR, PA

Position in REGN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$657

-$1,326,300 QoQ

Shares Held

861

-63.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,308

of 1,322 holders

Holding Since

Jun 2021

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STONERIDGE INVESTMENT PARTNERS LLC holds $518,854 across 6 Biotechnology names. REGN ranks #4 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	5,221	$368,863
2	CRMD	CorMedix Inc.	13,129	$103,062
3	NAGE	Niagen Bioscience, Inc.	14,477	$46,181
4	REGN	Regeneron Pharmaceuticals, Inc. This page	861	$657
5	IRD	Opus Genetics, Inc.	12,695	$47
6	ABUS	Arbutus Biopharma Corp	10,125	$44

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$657	861	-63.5%	Shares	Sole	2026-08-06
2025-09-30	$1,326,957	2,360	+148.4%	Shares	Sole	2025-10-31
2021-06-30	$530,613	950	—	Shares	Sole	2021-08-04
No filing history on record for this holder in this stock.